Literature DB >> 7798952

A Ewing's sarcoma cell line showing some, but not all, of the traits of a cholinergic neuron.

S O'Regan1, M F Diebler, F M Meunier, S Vyas.   

Abstract

The Ewing's sarcoma cell line ICB 112 was examined in detail for a cholinergic phenotype. Choline acetyltransferase activity (12.3 +/- 2.9 nmol/h/mg of protein) was associated with the presence of multiple mRNA species labeled with a human choline acetyltransferase riboprobe. Choline was taken up by the cells by a high-affinity, hemicholinium-3-sensitive transporter that was partially inhibited when lithium replaced sodium in the incubation medium; the choline taken up was quickly incorporated into both acetylcholine and phosphorylcholine. High-affinity binding sites for vesamicol, an inhibitor of vesicular acetylcholine transport, were also present. The mRNAs for synaptotagmin (p65) and the 15-kDa proteolipid were readily detected and were identical in size to those observed in cholinergic regions of the human brain. Cumulative acetylcholine efflux was increased by raising the extracellular potassium level or the addition of a calcium ionophore, but the time course of stimulated efflux was slow and persistent. These results show that this morphologically undifferentiated cell line is capable of acetylcholine synthesis and expresses markers for synaptic vesicles as well as proteins implicated in calcium-dependent release but lacks an organized release mechanism.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7798952     DOI: 10.1046/j.1471-4159.1995.64010069.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  6 in total

1.  An electric lobe suppressor for a yeast choline transport mutation belongs to a new family of transporter-like proteins.

Authors:  S O'Regan; E Traiffort; M Ruat; N Cha; D Compaore; F M Meunier
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

Review 2.  Novel Targeted Therapeutic Strategies for Ewing Sarcoma.

Authors:  Daria Fayzullina; Sergey Tsibulnikov; Mikhail Stempen; Brett A Schroeder; Naveen Kumar; Rajesh Kumar Kharwar; Arbind Acharya; Peter Timashev; Ilya Ulasov
Journal:  Cancers (Basel)       Date:  2022-04-14       Impact factor: 6.575

3.  Extraskeletal Ewing's sarcoma in a great toe of a young boy.

Authors:  Tatiana Karine Simon Cypel; Benjamin Meilik; Ronald Melvin Zuker
Journal:  Can J Plast Surg       Date:  2007

Review 4.  Ewing's sarcoma family of tumors.

Authors:  María Jesús Antuña García
Journal:  Clin Transl Oncol       Date:  2005-07       Impact factor: 3.340

5.  Modeling initiation of Ewing sarcoma in human neural crest cells.

Authors:  Cornelia von Levetzow; Xiaohua Jiang; Ynnez Gwye; Gregor von Levetzow; Long Hung; Aaron Cooper; Jessie Hao-Ru Hsu; Elizabeth R Lawlor
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

6.  Trk inhibition reduces cell proliferation and potentiates the effects of chemotherapeutic agents in Ewing sarcoma.

Authors:  Tiago Elias Heinen; Rafael Pereira Dos Santos; Amanda da Rocha; Michel Pinheiro Dos Santos; Patrícia Luciana da Costa Lopez; Marco Aurélio Silva Filho; Bárbara Kunzler Souza; Luís Fernando da Rosa Rivero; Ricardo Gehrke Becker; Lauro José Gregianin; Algemir Lunardi Brunetto; André Tesainer Brunetto; Caroline Brunetto de Farias; Rafael Roesler
Journal:  Oncotarget       Date:  2016-06-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.